Andrew Matthius

1 week ago | aacr.org | Andrew Matthius

While most individuals, including cancer patients, understand that exercise is good for overall health, several recent studies have highlighted just how much of an impact physical activity can have on survival and quality of life for patients with cancer.  Associations between exercise and benefits to cancer patients have long been studied.

1 month ago | aacr.org | Andrew Matthius

One of the resounding messages to emerge from the AACR Annual Meeting 2025, held April 25-30, was how cancer research is at a crossroads unlike anything researchers have seen before amid funding cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI).

1 month ago | aacr.org | Andrew Matthius

About 1 in 5 people currently develop cancer in their lifetime. By 2050, the global incidence of cancer is expected to increase from 20 million cases each year to over 35 million. These projections are one of the reasons Patricia M. LoRusso, DO, PhD(h), FAACR, made global health a key initiative of her tenure as President of the American Association for Cancer Research (AACR).  “Cancer is a global disease—it spares no continent, no country,” LoRusso, of Yale University, said during the meeting.

2 months ago | aacr.org | Andrew Matthius

How can we better map the evolution of cancer to help improve precision therapy? What role does age play in the development of cancer? What can be learned from tissues that rarely get cancer? What understudied targets are worth studying? These are among the questions that fascinate the early-career researchers selected as the 2025 NextGen Stars by the American Association for Cancer Research (AACR).

2 months ago | aacr.org | Andrew Matthius

Originally founded in 1887, the National Institutes of Health (NIH) has not only become a key component of medical research in the United States, but one of the foremost research centers in the world. Between 2010 and 2019, 354 out of the 356 therapeutics approved by the U.S. Food and Drug Administration (FDA) involved research that was at least in part funded by the NIH.